Looking ahead to 2020: Lawyers contemplate key US patent cases

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Looking ahead to 2020: Lawyers contemplate key US patent cases

Practitioners say that there could be significant IP shake-ups from the US Supreme Court, but that reform from Congress is unlikely

No one has 20/20 vision when it comes to the future, but with several Supreme Court cases granted certiorari, the rulings could have substantial implications for the IP space this year.



SCOTUS and patents

The Supreme Court ruling in Thryv v Click-To-Call Technologies is also expected to affect the patent space.

A provision of the America Invents Act (35 U.8.C. § 314(d)), states that inter partes review (IPR) may not be instituted if the petition requesting an IPR is filed more than one year after the petitioner receives a complaint alleging infringement. Another provision, says that the “determination by the director whether to institute an [IPR] under this section shall be final and non-appealable”.

According to the Supreme Court docket, the Federal Circuit held that a “PTAB decision to institute an IPR after finding that the … time bar [of one year] did not apply was appealable”.

The Supreme Court case is expected to rule on this decision and determine “whether 35 U.8.C. § 314(d) permits appeal of the PTAB's decision to institute an [IPR] upon finding that [the one-year] time bar did not apply”.



Section 101

In the coming year, lawyers will also keep their eyes on Congress to see if the legislative branch passes any IP reforms.

One of the most significant potential changes involves patent subject matter eligibility. Recent Supreme Court decisions have introduced judicial exceptions to patent eligibility, which limit the subject matters that can be patented.

Many in the IP community disagree with these decisions and argue that they have created uncertainty in the market. To address this, Senators Thom Tillis and Chris Coons have introduced draft legislation stipulating that “provisions of section 101 shall be construed in favour of eligibility”. Congress held hearings in 2019 to address section 101.  

Matthew Wagner, general counsel at PDC Brands, in Stamford, Connecticut, says that patent eligibility reforms are of interest to his company.

“We see that there are patents being applied for and granted on fairly limited ‘inventions’ which relate to techniques or beauty products that have been in existence for many, many years and decades, and parties asserting patent rights to which, upon examination, they’re not entitled,” says Wagner.

“That creates inefficiencies in the business because we have additional expense which we need to allocate towards new product development and defensive manoeuvres and the like.”

Still, many lawyers are sceptical that legislative change will actually happen this year. 

“I wish that I could say that legislation is forthcoming, but from what I’ve seen and from colleagues that I’ve had this conversation with, not many people are hopeful that we’re going to see anything in 2020,” says another source.

more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article